KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Return on Assets (2016 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Return on Assets for 17 consecutive years, with 0.02% as the latest value for Q1 2026.

  • For Q1 2026, Return on Assets rose 1.0% year-over-year to 0.02%; the TTM value through Mar 2026 reached 0.02%, up 1.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Assets hit 0.02% in Q1 2026 for Ionis Pharmaceuticals, up from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.07% in Q3 2025 and bottomed at 0.14% in Q3 2023.
  • Average Return on Assets over 5 years is 0.05%, with a median of 0.0% recorded in 2025.
  • Year-over-year, Return on Assets dropped -15bps in 2023 and then grew 20bps in 2025.
  • Ionis Pharmaceuticals' Return on Assets stood at 0.11% in 2022, then dropped by -14bps to 0.12% in 2023, then skyrocketed by 102bps to 0.0% in 2024, then crashed by -103bps to 0.0% in 2025, then surged by 24720bps to 0.02% in 2026.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.02%, 0.0%, and 0.07% for Q1 2026, Q4 2025, and Q3 2025 respectively.